Pharma & Biotech

We believe strong fundamentals as scientists and strategic problem solvers drive sound recommendations across a diverse set of clients, products, and markets.

Our project portfolio in pharma and biotech strategy is expansive. Our capabilities span all stages of the product lifecycle — from early-stage opportunity assessments to inform where a product’s greatest value may lie, to comprehensive launch planning and support.

We additionally support clients in setting strategy at the franchise and corporate level — including therapeutic area strategy, licensing and acquisitions, and corporate growth strategy. We have worked in every therapeutic area, and in both developed and emerging markets.

We work with organizations big and small, from top ten pharma companies to early startups. While the solutions should be right sized for the organization, our commitment to an exceptional project experience applies to all.

We are solving the problems at new frontiers for pharma. Below, explore a few examples that spotlight our recent work.

Project Types

Pipeline Discovery & Development

MOA Mapping and Prioritization

Pipeline Optimization

Indication Prioritization

Product Profile Development

Opportunity Assessment

Patient Journey Assessment

Brand Launch & Lifecycle Strategy

Demand Assessment

Patient & Prescriber Segmentation

Revenue Forecasting

Go-to-market Strategy

Global Launch Sequencing

Lifecycle Management


Therapeutic Area & Corporate Strategy

Therapeutic Area Assessment

Portfolio Strategy

Competitive Intelligence

Corporate Growth Strategy

Asset Screening and Diligence

Buy- and Sell-side Due Diligence

Case Studies

Let's talk about what we can accomplish together.

Pharma & Biotech Insight